These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 34858406)

  • 1. Age-Related Expression of IFN-λ1
    Gilbert C; Lefeuvre C; Preisser L; Pivert A; Soleti R; Blanchard S; Delneste Y; Ducancelle A; Couez D; Jeannin P
    Front Immunol; 2021; 12():750279. PubMed ID: 34858406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 innate effector associations and viral load in early nasopharyngeal infection.
    Liou TG; Adler FR; Cahill BC; Cox DR; Cox JE; Grant GJ; Hanson KE; Hartsell SC; Hatton ND; Helms MN; Jensen JL; Kartsonaki C; Li Y; Leung DT; Marvin JE; Middleton EA; Osburn-Staker SM; Packer KA; Shakir SM; Sturrock AB; Tardif KD; Warren KJ; Waddoups LJ; Weaver LJ; Zimmerman E; Paine R
    Physiol Rep; 2021 Feb; 9(4):e14761. PubMed ID: 33625796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial Antimicrobial Peptide/Protein and Cytokine Expression Profiles Obtained from Nasopharyngeal Swabs of SARS-CoV-2-Infected and Non-Infected Subjects.
    Gambichler T; Goesmann S; Skrygan M; Susok L; Schütte C; Hamdani N; Schmidt W
    Viruses; 2024 Sep; 16(9):. PubMed ID: 39339947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison by Age of the Local Interferon Response to SARS-CoV-2 Suggests a Role for IFN-ε and -ω.
    Pierangeli A; Gentile M; Oliveto G; Frasca F; Sorrentino L; Matera L; Nenna R; Viscido A; Fracella M; Petrarca L; D'Ettorre G; Ceccarelli G; Midulla F; Antonelli G; Scagnolari C
    Front Immunol; 2022; 13():873232. PubMed ID: 35903094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Nasal and Lung Tissues Infected
    Alfi O; Yakirevitch A; Wald O; Wandel O; Izhar U; Oiknine-Djian E; Nevo Y; Elgavish S; Dagan E; Madgar O; Feinmesser G; Pikarsky E; Bronstein M; Vorontsov O; Jonas W; Ives J; Walter J; Zakay-Rones Z; Oberbaum M; Panet A; Wolf DG
    J Virol; 2021 Jun; 95(14):e0013021. PubMed ID: 33893170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed induction of type I and III interferons mediates nasal epithelial cell permissiveness to SARS-CoV-2.
    Hatton CF; Botting RA; Dueñas ME; Haq IJ; Verdon B; Thompson BJ; Spegarova JS; Gothe F; Stephenson E; Gardner AI; Murphy S; Scott J; Garnett JP; Carrie S; Powell J; Khan CMA; Huang L; Hussain R; Coxhead J; Davey T; Simpson AJ; Haniffa M; Hambleton S; Brodlie M; Ward C; Trost M; Reynolds G; Duncan CJA
    Nat Commun; 2021 Dec; 12(1):7092. PubMed ID: 34876592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.
    Vanderheiden A; Ralfs P; Chirkova T; Upadhyay AA; Zimmerman MG; Bedoya S; Aoued H; Tharp GM; Pellegrini KL; Manfredi C; Sorscher E; Mainou B; Lobby JL; Kohlmeier JE; Lowen AC; Shi PY; Menachery VD; Anderson LJ; Grakoui A; Bosinger SE; Suthar MS
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32699094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type I and III interferon responses in SARS-CoV-2 infection.
    Kim YM; Shin EC
    Exp Mol Med; 2021 May; 53(5):750-760. PubMed ID: 33953323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Suppresses Type I and Type III Interferon Induction by Targeting RIG-I Signaling.
    Chang CY; Liu HM; Chang MF; Chang SC
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32295922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFN-λ uniquely promotes CD8 T cell immunity against SARS-CoV-2 relative to type I IFN.
    Solstad AD; Denz PJ; Kenney AD; Mahfooz NS; Speaks S; Gong Q; Robinson RT; Long ME; Forero A; Yount JS; Hemann EA
    JCI Insight; 2024 May; 9(13):. PubMed ID: 38973611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic functional analysis of SARS-CoV-2 proteins uncovers viral innate immune antagonists and remaining vulnerabilities.
    Hayn M; Hirschenberger M; Koepke L; Nchioua R; Straub JH; Klute S; Hunszinger V; Zech F; Prelli Bozzo C; Aftab W; Christensen MH; Conzelmann C; Müller JA; Srinivasachar Badarinarayan S; Stürzel CM; Forne I; Stenger S; Conzelmann KK; Münch J; Schmidt FI; Sauter D; Imhof A; Kirchhoff F; Sparrer KMJ
    Cell Rep; 2021 May; 35(7):109126. PubMed ID: 33974846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Defensins Inhibit SARS-CoV-2 Infection by Blocking Viral Entry.
    Xu C; Wang A; Marin M; Honnen W; Ramasamy S; Porter E; Subbian S; Pinter A; Melikyan GB; Lu W; Chang TL
    Viruses; 2021 Jun; 13(7):. PubMed ID: 34206990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type I and III IFN-mediated antiviral actions counteracted by SARS-CoV-2 proteins and host inherited factors.
    Quarleri J; Delpino MV
    Cytokine Growth Factor Rev; 2021 Apr; 58():55-65. PubMed ID: 33608189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulated early transcriptional signatures linked to mast cell and interferon responses are implicated in COVID-19 severity.
    MacCann R; Leon AAG; Gonzalez G; Carr MJ; Feeney ER; Yousif O; Cotter AG; de Barra E; Sadlier C; Doran P; Mallon PW
    Front Immunol; 2023; 14():1166574. PubMed ID: 37261339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Update on Innate Immune Responses during SARS-CoV-2 Infection.
    Zhang Y; Chen S; Jin Y; Ji W; Zhang W; Duan G
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The RNA sensor MDA5 detects SARS-CoV-2 infection.
    Sampaio NG; Chauveau L; Hertzog J; Bridgeman A; Fowler G; Moonen JP; Dupont M; Russell RA; Noerenberg M; Rehwinkel J
    Sci Rep; 2021 Jul; 11(1):13638. PubMed ID: 34211037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cigarette smoke combined with Toll-like receptor 3 signaling triggers exaggerated epithelial regulated upon activation, normal T-cell expressed and secreted/CCL5 expression in chronic rhinosinusitis.
    Yamin M; Holbrook EH; Gray ST; Harold R; Busaba N; Sridhar A; Powell KJ; Hamilos DL
    J Allergy Clin Immunol; 2008 Dec; 122(6):1145-1153.e3. PubMed ID: 18986692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-related Differences in the Nasal Mucosal Immune Response to SARS-CoV-2.
    Koch CM; Prigge AD; Anekalla KR; Shukla A; Do Umehara HC; Setar L; Chavez J; Abdala-Valencia H; Politanska Y; Markov NS; Hahn GR; Heald-Sargent T; Sanchez-Pinto LN; Muller WJ; Singer BD; Misharin AV; Ridge KM; Coates BM
    Am J Respir Cell Mol Biol; 2022 Feb; 66(2):206-222. PubMed ID: 34731594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type I and III interferons are good markers to monitor COVID-19 pathophysiology.
    Darif D; Ejghal R; Desterke C; Outlioua A; Hammi I; Lemrani M; Hilali F; Guessous F; Zaid Y; Akarid K
    Cytokine; 2023 May; 165():156172. PubMed ID: 36924609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.